A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection

作者：Berres Marie Luise; Papen Sven; Pauels Katrin; Schmitz Petra; Zaldivar Mirko Moreno; Hellerbrand Claus; Mueller Tobias; Berg Thomas; Weiskirchen Ralf; Trautwein Christian; Wasmuth Hermann E^*

来源：Journal of Hepatology, 2009, 50(2): 370-376.

DOI：10.1016/j.jhep.2008.09.016

• Liver fibrosis
• YKL-40
• Gene polymorphisms

Background/Aims: YKL-40 is a chitinase-like protein involved in matrix remodelling and a non-invasive fibrosis marker. We assessed whether a functional promoter polymorphism in CHI3L1, encoding YKL-40, is associated with HCV-induced liver fibrosis and influences YKL-40 serum concentrations.
Methods:The CHI3L1 - 131G -> C promoter polymorphism was genotyped in two cohorts of HCV infected patients (n = 440) by 5'-endonuclease assays. Histological fibrosis scores and YKL-40 serum levels (ELISA) were associated with CHI3L1 - 131G -> C by quantitative and qualitative genetic analyses and corrected by multivariate analysis.
Results: CHI3L1 - 131 G -> C genotype was strongly associated with the stage of liver fibrosis in the screening (n = 265, P = 0.001) and validation cohort (n = 175, P = 0.009). Homozygous carriers of the G allele were protected from severe fibrosis (F3/F4). This association was confirmed after correction for age and gender. Functionally, the G allele was associated with reduced serum levels of YKL-40 in HCV infected patients (P = 0.002).
Conclusions: The CHI3L1 promoter polymorphism - 131 G -> C determines YKL-40 serum levels and is associated with the severity of HCV-induced liver fibrosis. These results suggest a functional role of YKL-40 in liver fibrogenesis and should be taken into account when using YKL-40 as a non-invasive fibrosis marker.

• 出版日期2009-2